IE
IE · IE · IE-PA-EU/1/24/1823/004
WEZENLA 130 mg Concentrate for solution for infusion
ATC L04AC05
Last synced from HPRA (Ireland) on
Identification
ManufacturerAmgen Technology (Ireland) UC
CountryIE (IE)
ATC codeL04AC05
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026
Packs · 1
- ie_pa_numberEU/1/24/1823/004
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Concentrate for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"L04AC05"
],
"strength": null,
"pa_number": "EU/1/24/1823/004",
"substances": [
"Ustekinumab"
],
"legal_basis": "Similar biological application (Article 10(4) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "20/06/2024",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Related drugs
Other records sharing ATC code L04AC05.
Access this data programmatically
Query WEZENLA 130 mg Concentrate for solution for infusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.